USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:USNA • US90328M1071

21.66 USD
-0.04 (-0.18%)
At close: Feb 2, 2026
21.66 USD
0 (0%)
After Hours: 2/2/2026, 8:04:00 PM
Fundamental Rating

5

Taking everything into account, USNA scores 5 out of 10 in our fundamental rating. USNA was compared to 37 industry peers in the Personal Care Products industry. USNA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. USNA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year USNA was profitable.
  • USNA had a positive operating cash flow in the past year.
  • Each year in the past 5 years USNA has been profitable.
  • Each year in the past 5 years USNA had a positive operating cash flow.
USNA Yearly Net Income VS EBIT VS OCF VS FCFUSNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.34%, USNA is in line with its industry, outperforming 56.76% of the companies in the same industry.
  • The Return On Equity of USNA (3.22%) is better than 64.86% of its industry peers.
  • USNA's Return On Invested Capital of 4.04% is in line compared to the rest of the industry. USNA outperforms 54.05% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for USNA is in line with the industry average of 11.85%.
  • The 3 year average ROIC (10.32%) for USNA is well above the current ROIC(4.04%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.34%
ROE 3.22%
ROIC 4.04%
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
USNA Yearly ROA, ROE, ROICUSNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • With a Profit Margin value of 1.86%, USNA perfoms like the industry average, outperforming 59.46% of the companies in the same industry.
  • In the last couple of years the Profit Margin of USNA has declined.
  • With a Operating Margin value of 4.58%, USNA perfoms like the industry average, outperforming 54.05% of the companies in the same industry.
  • In the last couple of years the Operating Margin of USNA has declined.
  • Looking at the Gross Margin, with a value of 79.18%, USNA belongs to the top of the industry, outperforming 94.59% of the companies in the same industry.
  • USNA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.58%
PM (TTM) 1.86%
GM 79.18%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
USNA Yearly Profit, Operating, Gross MarginsUSNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so USNA is still creating some value.
  • USNA has less shares outstanding than it did 1 year ago.
  • USNA has less shares outstanding than it did 5 years ago.
  • USNA has a worse debt/assets ratio than last year.
USNA Yearly Shares OutstandingUSNA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
USNA Yearly Total Debt VS Total AssetsUSNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • USNA has an Altman-Z score of 3.78. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
  • USNA's Altman-Z score of 3.78 is fine compared to the rest of the industry. USNA outperforms 75.68% of its industry peers.
  • There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.78
ROIC/WACC0.47
WACC8.65%
USNA Yearly LT Debt VS Equity VS FCFUSNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 2.23 indicates that USNA has no problem at all paying its short term obligations.
  • USNA has a Current ratio (2.23) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.46 indicates that USNA should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.46, USNA is in line with its industry, outperforming 56.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.46
USNA Yearly Current Assets VS Current LiabilitesUSNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

  • The earnings per share for USNA have decreased strongly by -30.74% in the last year.
  • Measured over the past years, USNA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.07% on average per year.
  • USNA shows a small growth in Revenue. In the last year, the Revenue has grown by 5.88%.
  • The Revenue has been decreasing by -4.23% on average over the past years.
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%

3.2 Future

  • USNA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.30% yearly.
  • The Revenue is expected to grow by 6.09% on average over the next years.
EPS Next Y-31.74%
EPS Next 2Y-12.54%
EPS Next 3Y3.3%
EPS Next 5YN/A
Revenue Next Year8.86%
Revenue Next 2Y6.08%
Revenue Next 3Y6.09%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USNA Yearly Revenue VS EstimatesUSNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
USNA Yearly EPS VS EstimatesUSNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.05, which indicates a very decent valuation of USNA.
  • Based on the Price/Earnings ratio, USNA is valued cheaper than 86.49% of the companies in the same industry.
  • USNA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.41.
  • A Price/Forward Earnings ratio of 10.89 indicates a reasonable valuation of USNA.
  • 83.78% of the companies in the same industry are more expensive than USNA, based on the Price/Forward Earnings ratio.
  • USNA is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.05
Fwd PE 10.89
USNA Price Earnings VS Forward Price EarningsUSNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 94.59% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.91
USNA Per share dataUSNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • USNA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.54%
EPS Next 3Y3.3%

More info and screens

0

5. Dividend

5.1 Amount

  • USNA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

USANA HEALTH SCIENCES INC

NYSE:USNA (2/2/2026, 8:04:00 PM)

After market: 21.66 0 (0%)

21.66

-0.04 (-0.18%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)10-09
Earnings (Next)02-17
Inst Owners61.98%
Inst Owner Change-1.91%
Ins Owners0.6%
Ins Owner Change0.03%
Market Cap395.94M
Revenue(TTM)912.67M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (83.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)2.5%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)0.58%
EPS NY rev (3m)2.35%
Revenue NQ rev (1m)2.34%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)0.56%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 11.05
Fwd PE 10.89
P/S 0.43
P/FCF N/A
P/OCF 12.56
P/B 0.75
P/tB 1.61
EV/EBITDA 3.91
EPS(TTM)1.96
EY9.05%
EPS(NY)1.99
Fwd EY9.18%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY7.96%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.69
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.22%
ROCE 6.88%
ROIC 4.04%
ROICexc 5.3%
ROICexgc 13.62%
OM 4.58%
PM (TTM) 1.86%
GM 79.18%
FCFM N/A
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexgc growth 3Y-27.3%
ROICexgc growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 973.94%
Cap/Sales 23.69%
Interest Coverage 62.89
Cash Conversion 49.24%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.46
Altman-Z 3.78
F-Score5
WACC8.65%
ROIC/WACC0.47
Cap/Depr(3y)569.36%
Cap/Depr(5y)383.35%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
EPS Next Y-31.74%
EPS Next 2Y-12.54%
EPS Next 3Y3.3%
EPS Next 5YN/A
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
Revenue Next Year8.86%
Revenue Next 2Y6.08%
Revenue Next 3Y6.09%
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year37.8%
EBIT Next 3Y22.6%
EBIT Next 5YN/A
FCF growth 1Y-347.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.96%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%

USANA HEALTH SCIENCES INC / USNA FAQ

What is the fundamental rating for USNA stock?

ChartMill assigns a fundamental rating of 5 / 10 to USNA.


Can you provide the valuation status for USANA HEALTH SCIENCES INC?

ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.


Can you provide the profitability details for USANA HEALTH SCIENCES INC?

USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 6 / 10.


What is the financial health of USANA HEALTH SCIENCES INC (USNA) stock?

The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 7 / 10.


Can you provide the expected EPS growth for USNA stock?

The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to decline by -31.74% in the next year.